Literature DB >> 25361867

Tunable CD44-specific cellular retargeting with hyaluronic acid nanoshells.

Morten F Ebbesen1, Morten Tj Olesen, Mikkel C Gjelstrup, Malgorzata M Pakula, Esben Ku Larsen, Irene M Hansen, Pernille L Hansen, Jan Mollenhauer, Birgitte M Malle, Kenneth A Howard.   

Abstract

PURPOSE: In this work we specifically investigate the molecular weight (Mw) dependent combinatorial properties of hyaluronic acid (HA) for exhibiting stealth and targeting properties using different Mw HA nanoshells to tune nanoparticle retargeting to CD44-expressing cancer cells.
METHODS: HA of different Mw was covalently grafted onto model polystyrene nanoparticles and advanced surface analysis by X-ray photoelectron spectroscopy performed to quantify and evaluate the effect of the coating procedure. Specific CD44-mediated retargeting was investigated by flow cytometry and confocal microscopy using isogenic D44-deficient and CD44-expressing MCF-7 breast adenocarcinoma cells.
RESULTS: Surface analysis demonstrated effective surface coating with 33, 260 and 900 kDa HA resulting in increased colloidal stability and highly negative surface charge due to presentation of up to 4.7% carboxyl groups that indicates an extended and non-constricted HA polymer surface. Reduced non-specific particle interaction in CD44(-) cells was shown for all HA nanoshells but CD44-dependent cellular retargeting and internalization in CD44(+) cells was highly dependent on the coating HA Mw properties.
CONCLUSION: The combination of advanced surface characterization and evaluation of particle interactions in isogenic cells with and without CD44 receptor demonstrates direct evidence for the dual capacity of HA for stealth and CD44-mediated retargeting tunable by the HA molecular weight.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25361867     DOI: 10.1007/s11095-014-1552-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  34 in total

Review 1.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

Authors:  Donald E Owens; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2005-11-21       Impact factor: 5.875

2.  Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes.

Authors:  Hussaini Syed Sha Qhattal; Xinli Liu
Journal:  Mol Pharm       Date:  2011-07-05       Impact factor: 4.939

3.  Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells.

Authors:  R E Eliaz; F C Szoka
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

4.  Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan.

Authors:  Patricia M Wolny; Suneale Banerji; Céline Gounou; Alain R Brisson; Anthony J Day; David G Jackson; Ralf P Richter
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

5.  The intracellular drug delivery and anti tumor activity of doxorubicin loaded poly(gamma-benzyl L-glutamate)-b-hyaluronan polymersomes.

Authors:  Kamal K Upadhyay; Anant N Bhatt; Anil K Mishra; Bilikere S Dwarakanath; Sanyog Jain; Christophe Schatz; Jean-François Le Meins; Abdullah Farooque; Godugu Chandraiah; Amit K Jain; Ambikanandan Misra; Sébastien Lecommandoux
Journal:  Biomaterials       Date:  2010-01-06       Impact factor: 12.479

6.  Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas.

Authors:  Hideo Shigeishi; Shinichi Fujimoto; Misato Hiraoka; Shigehiro Ono; Masayuki Taki; Kouji Ohta; Koichiro Higashikawa; Nobuyuki Kamata
Journal:  Int J Oncol       Date:  2009-06       Impact factor: 5.650

7.  The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic.

Authors:  Mark E Davis
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

8.  Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.

Authors:  I Hamad; A C Hunter; J Szebeni; S M Moghimi
Journal:  Mol Immunol       Date:  2008-10-11       Impact factor: 4.407

9.  Surface analysis of PEGylated nano-shields on nanoparticles installed by hydrophobic anchors.

Authors:  M F Ebbesen; B Whitehead; B Ballarin-Gonzalez; P Kingshott; K A Howard
Journal:  Pharm Res       Date:  2013-04-12       Impact factor: 4.200

10.  Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.

Authors:  A Bartolazzi; R Peach; A Aruffo; I Stamenkovic
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Bioinspired Shielding Strategies for Nanoparticle Drug Delivery Applications.

Authors:  Neetu M Gulati; Phoebe L Stewart; Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2018-05-15       Impact factor: 4.939

2.  Non-covalent Encapsulation of siRNA with Cell-Penetrating Peptides.

Authors:  Martina Tuttolomondo; Henrik J Ditzel
Journal:  Methods Mol Biol       Date:  2021

3.  Human DMBT1-Derived Cell-Penetrating Peptides for Intracellular siRNA Delivery.

Authors:  Martina Tuttolomondo; Cinzia Casella; Pernille Lund Hansen; Ester Polo; Luciana M Herda; Kenneth A Dawson; Henrik J Ditzel; Jan Mollenhauer
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-29       Impact factor: 8.886

4.  Atomistic fingerprint of hyaluronan-CD44 binding.

Authors:  Joni Vuorio; Ilpo Vattulainen; Hector Martinez-Seara
Journal:  PLoS Comput Biol       Date:  2017-07-17       Impact factor: 4.475

Review 5.  Recent applications of cell-penetrating peptide guidance of nanosystems in breast and prostate cancer.

Authors:  Samuel Longoria-García; Celia Nohemi Sánchez-Domínguez; Hugo Leonid Gallardo-Blanco
Journal:  Oncol Lett       Date:  2022-02-01       Impact factor: 2.967

6.  Hyaluronic acid reagent functional chitosan-PEI conjugate with AQP2-siRNA suppressed endometriotic lesion formation.

Authors:  Meng-Dan Zhao; Jin-Lin Cheng; Jing-Jing Yan; Feng-Ying Chen; Jian-Zhong Sheng; Dong-Li Sun; Jian Chen; Jing Miao; Run-Ju Zhang; Cai-Hong Zheng; He-Feng Huang
Journal:  Int J Nanomedicine       Date:  2016-03-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.